Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-15-022873
Filing Date
2015-04-15
Accepted
2015-04-15 11:16:00
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v406669_10k.htm 10-K 562312
2 EXHIBIT 31.1 v406669_ex31-1.htm EX-31.1 10181
3 EXHIBIT 31.2 v406669_ex31-2.htm EX-31.2 9912
4 EXHIBIT 32 v406669_ex32.htm EX-32 3833
  Complete submission text file 0001144204-15-022873.txt   4288834

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ovit-20141231.xml EX-101.INS 541038
6 XBRL TAXONOMY EXTENSION SCHEMA ovit-20141231.xsd EX-101.SCH 37621
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovit-20141231_cal.xml EX-101.CAL 33306
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovit-20141231_def.xml EX-101.DEF 211497
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovit-20141231_lab.xml EX-101.LAB 272247
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovit-20141231_pre.xml EX-101.PRE 256445
Mailing Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245
Business Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245 210 677 6000
ONCOVISTA INNOVATIVE THERAPIES, INC (Filer) CIK: 0001094847 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28347 | Film No.: 15770911
SIC: 2834 Pharmaceutical Preparations